1. Home
  2. DTSS vs ENSC Comparison

DTSS vs ENSC Comparison

Compare DTSS & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

N/A

Current Price

$0.44

Market Cap

8.2M

Sector

Technology

ML Signal

N/A

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

N/A

Current Price

$0.39

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DTSS
ENSC
Founded
2014
2003
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
8.2M
IPO Year
2026
2017

Fundamental Metrics

Financial Performance
Metric
DTSS
ENSC
Price
$0.44
$0.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $4.08
AVG Volume (30 Days)
54.9K
★ 266.8K
Earning Date
12-01-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.24
EPS
★ N/A
N/A
Revenue
N/A
★ $5,066,650.00
Revenue This Year
N/A
$8.55
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.46
$0.23
52 Week High
$2.29
$1.85

Technical Indicators

Market Signals
Indicator
DTSS
ENSC
Relative Strength Index (RSI) 30.19 44.02
Support Level N/A $0.33
Resistance Level $0.77 $0.44
Average True Range (ATR) 0.05 0.04
MACD -0.01 0.00
Stochastic Oscillator 0.00 59.37

Price Performance

Historical Comparison
DTSS
ENSC

About DTSS Datasea Inc.

Datasea Intelligent Technology Ltd, formerly known as Datasea Inc, is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC) markets.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: